Yahoo still has a $3.83 1-year price target on this. That would be a 10-bagger and a market cap of half a billion dollars. Too funny.
4 years later and still under water, bad stock to buy I wish I had never bought this pcs of #$%$.
One of the sh%t stock, screwed so many small investors
Volume drying up with movements of half a cent or less. Could be near the end of the line now. Get the defibrillators!
Loser. This is pure #$%$
EU commercial & development partnership 2H2017 EU phase 3 trial start 1H2018 EU phase 3 data 2H2019 EU submission to EMA 1H2020
where are those posters who were yelping 2.00 5.00 an acquisition target.. buy big boy stocks
I have been in this stock for a very long time, before the reverse split. Historically this stock has sucked for 10 years and will continue to suck. Phil, Phil are you still out there? Do you still think this is a strong buy? I dare you to respond.
I have held this stock for over two years and still haven't made a dime what a pcs of #$%$
10,000th of a Penney it's trading. Your guys will be rich.
Dang. And I thought we had a bonerfied rally going ... Oh well.
This sh#t stock screwed lot of investors like me who got struck at $0.65 levels.
Just love the insider purchases. Too funny.
Not a peep from AMAG analyst on Brem. Here's JPMorgan:
Remain cautious on AMAG shares, but closely watching Intrarosa uptake. While we acknowledge that Makena may not face the immediate sharp decline typical with multi-player generic competition in February, we see multiple events that would need to play out to begin to diversify revenues away from Makena. Along these lines, we see the story of AMAG shares ultimately hinging on commercial execution beginning with the Intrarosa launch this fall, the successful on-time approval and conversion of SC Makena next spring, and growth/sales trajectory for Feraheme on the back of the IDA label expansion. While these represent multiple potential opportunities, we continue to see the durability of the Makena franchise hinging on the pace/number of generics that enter and see an on-time approval for auto-injector as a key de-risking event for the stock whether Intrarosa launches quickly or not.
Any more fake news Kevin?
Okay, broke under 40, let's see if it closes there. If you have the patience to wait 2 years, media hype will create a little rally, MAYBE...or maybe not. Only for gambling money though. Not the type of stock to be considered an investment as this could go to single digits in a heartbeat.
Is it time to make a move on PTN? Yo you should really check out Awe.Som.e.Sto-cks., they seem on point with their stocks.
That was an interesting report by Amag. Barely a peep, must be they are holding this close for some reason. May be time to purchase Amag. They did say they expended $16 million on NDA costs via PTN????Hmmmmmmmm
These daily $0.0003 moves are a pathetic joke. This hapless mess has been a loser for going on two decades now. Hard to believe there are any longs left here after taking it in the kiester repeatedly by this sham company.
I am hereby presenting Ron with a Rhodes Scholarship, for his unique genius discovery that PTN is a horrible stock. Furthermore, we should collectively nominate him for a nobel peace prize in stock analytics, for sharing this wonderful new insight with the board!!! May I ask you Ron, how you deduced so brilliantly that this was a horrible stock, when everything about it has been so spectacular for the past 2 decades??? How did you ever figure out what has clearly eluded the entire investment world for nearly a quarter century???
Omg...believer...check out the BUTTHURT reply Ron left for you... or probably ME actually...i can't stop LAUGHING!! OMG, i..i.. I just CANT!! 🤣🤣🤣